NCT02446925 Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study Status TERMINATED Phase NA
NCT02436044 HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC Status APPROVED_FOR_MARKETING Phase N/A
NCT02435953 TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02435433 A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein Status COMPLETED Phase PHASE3
NCT02432963 Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02426450 RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC Status UNKNOWN Phase PHASE2
NCT02425605 Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02424955 Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation Status COMPLETED Phase NA
NCT02423239 A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours Status UNKNOWN Phase PHASE1
NCT02415036 Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT02412579 Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation Status COMPLETED Phase N/A
NCT02400788 Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE1/PHASE2
NCT02399735 Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation Status UNKNOWN Phase PHASE1
NCT02399033 Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy Status UNKNOWN Phase PHASE4
NCT02395523 Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma Status COMPLETED Phase NA